The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.

Blood componente removal/adverse effects Blood donors Brazil Platelet apheresis

Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 30 11 2021
revised: 22 02 2022
accepted: 13 03 2022
pubmed: 30 3 2022
medline: 8 9 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

Immediate adverse reactions experienced during donation decrease return rates among whole-blood donors, but little is known about this effect among platelet apheresis donors. We investigated the impact of immediate adverse reactions on the return rates of volunteer apheresis platelet donors. In a sample of 4108 consecutive platelet apheresis donors seen from August 2016 through June 2019, we evaluated whether immediate adverse reactions were associated with returning for a subsequent platelet apheresis donation within a 12-month period. We used propensity score matching to compare donors with and without adverse reactions. An immediate adverse reaction occurred in 312 (7.6%) donors; 98.5% were mild, and 0.3% were severe. Of the original 4108 platelet apheresis donors, only 3211 (72.3%) returned for a subsequent donation within 12 months. Experiencing an immediate adverse reaction during the donation process significantly decreased the return rate for a subsequent donation [HR= 0.74 (0.63-0.87)], especially among female donors [HR= 0.70 (0.53-0.93)], donors aged < 30 years [HR= 0.71 (0.54-0.94)], with a high school educational level [0.63 (0.49-0.81)], donors donating for the first time [HR= 0.73 (0.59-0.90)], and repeat donors with a previous platelet apheresis donation more than 180 days prior [HR= 0.68 (0.50-0.93)]. Even mild adverse events reduce the return rates for a subsequent donation among platelet apheresis donors. Female donors, younger donors, and first-time donors are at higher risk of not returning after an immediate adverse reaction. Preventing the incidence of immediate adverse reactions during platelet apheresis donation may increase the rate of donor retention.

Identifiants

pubmed: 35346602
pii: S1473-0502(22)00091-X
doi: 10.1016/j.transci.2022.103424
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

103424

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None declared.

Auteurs

Cássio Lins Gil de Farias (CLG)

Departamento de Hematologia, Hemoterapia e Terapia Celular da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.

Lucas Bassolli (L)

Departamento de Hematologia, Hemoterapia e Terapia Celular da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Laboratório de Investigação Médica na Patogênese e Terapia dirigida em Onco-imuno-hematologia (LIM-31), Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.

Alfredo Mendrone-Junior (A)

Laboratório de Investigação Médica na Patogênese e Terapia dirigida em Onco-imuno-hematologia (LIM-31), Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Fundação Pró-Sangue - Hemocentro de São Paulo, São Paulo, SP, Brazil.

Cyntia de Araújo Arrais (C)

Laboratório de Investigação Médica na Patogênese e Terapia dirigida em Onco-imuno-hematologia (LIM-31), Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.

Amanda Duran (A)

Departamento de Hematologia, Hemoterapia e Terapia Celular da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.

Vanderson Rocha (V)

Departamento de Hematologia, Hemoterapia e Terapia Celular da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Laboratório de Investigação Médica na Patogênese e Terapia dirigida em Onco-imuno-hematologia (LIM-31), Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Fundação Pró-Sangue - Hemocentro de São Paulo, São Paulo, SP, Brazil; Haematology Department, Churchill Hospital, NHS-BT, Oxford University, Oxford, UK.

Cesar de Almeida-Neto (C)

Fundação Pró-Sangue - Hemocentro de São Paulo, São Paulo, SP, Brazil; Disciplina de Ciências Médicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil. Electronic address: cesarnt@uol.com.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH